CLSI M45A provides guidance to clinical microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI/NCCLS documents M2, M7, or M11. The tabular information in this document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in this guideline.
CLSI M45A:2006
Original price was: $115.75.$57.00Current price is: $57.00.
Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline, M45-A
Clinical and Laboratory Standards Institute , 05/30/2006
Pages: 76
